Sep
5
2019
On demand

No room for error: preparing for inevitable variability in the cell and gene therapy supply chain

Orchestrating cell and gene therapy logistics is complex and susceptible to variability at each point of the supply chain. When shipments are life-critical, delays and oversights can be fatal.

As operations scale from small populations in early-phase clinical trials to larger populations in late-stage trials and commercial launch, your supply chain complexity and risk increases. When issues arise, and a person’s life relies on your product being delivered intact and on time, you need established systems, processes and relationships in place to reroute, problem solve, and ultimately, deliver.

Watch this on demand webinar for expert insights into navigating variability in the cell and gene therapy supply chain.

During this webinar our panelists explore:

  • The complexity and variability of cell and gene therapy supply chains and potential impacts on manufacturing and therapy delivery deadlines
  • How established relationships and well-designed, evidence-backed supply chain models can help ensure consistent, reliable product delivery
  • The criticality of contingency planning and emergency preparedness to mitigate risk, minimize disruption and overcome the inevitable variability inherent to human-based therapy delivery supply chains

Jamie Margolis
Director, Cell & Gene Therapy at Be The Match BioTherapies
Lisa Fox
Co-Founder at Broken Lance Biotech Consulting
Raymond Hornung
Senior Manager, Logistics at Be The Match BioTherapies
Rob Margolin
Vice President, Corporate Development & Strategy at TrakCel Ltd
Jason Krentz
CTO at Tmunity Therapeutics Inc

SPEAKERS

Jamie Margolis
Director, Cell & Gene Therapy at Be The Match BioTherapies
Lisa Fox
Co-Founder at Broken Lance Biotech Consulting
Raymond Hornung
Senior Manager, Logistics at Be The Match BioTherapies
Rob Margolin
Vice President, Corporate Development & Strategy at TrakCel Ltd
Jason Krentz
CTO at Tmunity Therapeutics Inc

You might also like

Strategic supply chain design: flexibility and scalability considerations for...

N Kulkarni, PhD
G Linton, RA, AIA, LEED AP BD+C
Niranjan Kulkarni, PhD
Niranjan Kulkarni, PhD
Senior Director, Consulting Services at CRB
Grace Linton, RA, AIA, LEED AP BD+C
Grace Linton, RA, AIA, LEED AP BD+C
Director of Process Architecture at CRB
28 April 2022
Watch now

Supply chain efficiency and sourcing for scaling your gene therapy operation

C Martin
D Young
Céline  Martin
Céline Martin
Senior Product Manager, Gene Therapy at Thermo Fisher Scientific
Don Young
Don Young
Senior Global Product Manager, Single-Use Technologies at Thermo Fisher Scientific
7 April 2022
Watch now

Rapid translation of a cellular therapeutic: Choosing product & process development...

A Patel
J Candiello
Ashish Patel
Ashish Patel
Clinical Senior Lecturer and Consultant Vascular and Endovascular Surgeon at Foundation for the National Institutes of Health
Joseph Candiello
Joseph Candiello
Senior Product Manager at RoosterBio Inc
10 March 2022
Watch now

Cell and gene therapy matures: Streamlining and smoothing the path to commercialization

M Hewitt
Matt Hewitt, PhD
Matt Hewitt, PhD
Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
11 January 2022
Watch now

Considerations for developing scalable and efficient collection network processes

L Anderson,
S Butler,
A Montalvo
Lacey Anderson
Lacey Anderson
Senior Manager, Collection Network Management, Be The Match BioTherapies
Sara Butler
Sara Butler
Network Liaison, Be The Match BioTherapies
Allison Montalvo,
Allison Montalvo,
Program Manager, Oncology, Janssen ( A division of J&J)
28 October 2021
Watch now